Chad Cowan

Fondatore presso Clade Therapeutics, Inc.

Consumer Services

Health Technology

Profilo

Chad Cowan is the founder of CRISPR Therapeutics AG, where he held the title of Head-Research until his departure in an unknown year.
He is also the founder of Clade Therapeutics, Inc. Currently, Dr. Cowan is an Associate Professor at Harvard University.
Dr. Cowan received his undergraduate degree from the University of Kansas and his doctorate from The University of Texas Southwestern Medical Center.

Posizioni attive di Chad Cowan

Società	Posizione	Inizio
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-
Clade Therapeutics, Inc. Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation.	Fondatore	-

Tutte le posizioni attive di Chad Cowan

Precedenti posizioni note di Chad Cowan

Società	Posizione	Fine
CRISPR THERAPEUTICS AG	Fondatore	-

Vedi nel dettaglio l'esperienza di Chad Cowan

Formazione di Chad Cowan

University of Kansas	Undergraduate Degree
The University of Texas Southwestern Medical Center	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Chad Cowan

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CRISPR THERAPEUTICS AG	Health Technology

Aziende private	1
Clade Therapeutics, Inc. Clade Therapeutics, Inc. BiotechnologyHealth Technology Clade Therapeutics, Inc. is a company that aims to discover and deliver next-generation cell medicines to improve the lives of patients in need. Clade Therapeutics is based in Boston, MA. The company is initially focused on harnessing the potential of "cloaked" immune cells for cancer treatment. Clade Therapeutics is led by a world-class team of company builders and scientific innovators with unparalleled expertise in generating stem cell-derived adult T, NK, and B cells. The company is supported by a premier investor syndicate, including Lifesci Venture Partners, Emerson Collective, and Bristol-Myers Squibb. The company was founded by Jim Glasheen, Deepta Bhattacharya, Chris Sturgeon, Gustavo Mostoslavsky, Leandro Vetcher, Chad Cowan, and Chad Cowan has been the CEO since incorporation.	Health Technology